4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Metastase in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iyama, S; Kano, J; Kim, Y; Morishita, Y; Noguchi, M; Sakashita, S; Satomi, K; Shiba-Ishii, A; Shiozawa, T | 1 |
Chaible, LM; Cogliati, B; Da Silva, TC; Dagli, ML; Fukumasu, H; Latorre, AO; Mackowiak, II; Mennecier, G; Mori, CM; Nagamine, MK; Sanches, DS; Torres, LN | 1 |
Deng, X; Xu, L | 1 |
3 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Metastase
Article | Year |
---|---|
Stratifin accelerates progression of lung adenocarcinoma at an early stage.
Topics: 14-3-3 Proteins; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Disease Progression; Exoribonucleases; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Transgenic; Neoplasm Metastasis; Neoplasm Staging; Nitrosamines; Xenograft Model Antitumor Assays | 2015 |
Chronic exposure of lung alveolar epithelial type II cells to tobacco-specific carcinogen NNK results in malignant transformation: a new in vitro lung carcinogenesis model.
Topics: Animals; Blotting, Western; Carcinogens; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Epithelial-Mesenchymal Transition; Female; Fluorescent Antibody Technique, Indirect; Immunoenzyme Techniques; In Vitro Techniques; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Nicotiana; Nitrosamines; Pulmonary Alveoli; Wound Healing | 2014 |
Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion.
Topics: Blotting, Western; Calpain; Carcinogens; Cell Line, Tumor; Cell Movement; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Flavonoids; Gene Silencing; Genetic Vectors; Humans; Immunoprecipitation; Lung Neoplasms; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Nicotiana; Nitrosamines; Phosphorylation; RNA Interference; RNA, Small Interfering; Signal Transduction | 2004 |